Global Clonorchiasis Market -Highlights Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and fareastern Russia. China has the largest population of infected people. In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur. Request Sample with New Market Trends @
https://www.marketresearchfuture.com/sample_request/4686 Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market. Global Clonorchiasis Market -Key Players Pfizer (U.S) Bayer AG (Germany) Provet (Switzerland) Virbac (India) Cipla (India) Novartis AG (Switzerland) CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India) Merck & Co., Inc. (U.S.) F. Hoffmann-La Roche Ltd. (Switzerland) Abbott (U.S.) Arsanis, Inc. (Austria) Novabiotics (U.K.) GlaxoSmithKline plc. (U.K.) The global clonorchiasis market is expected to grow at a CAGR of 5.4% during the forecast period. Global Clonorchiasis Market -Segmentation The Global Clonorchiasis Market is segmented on the basis of parasites, therapy, and end users.On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, and others. On the basis of the therapy, the market is segmented into diagnosis and treatment. The diagnosis is further segmented into microscopic examination, X-ray, serologic tests, and others. The treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and others.On the basis of end users, the market is segmented into hospital, clinics, and others. Access Report Details with TOC @ https://www.marketresearchfuture.com/reports/clonorchiasis-
market-4686
Global Clonorchiasis Market -Regional Analysis The Americas dominate the global clonorchiasis market owing to a large geriatric population, strong government support for research & development, and high healthcare spending. According to the Centers for Disease Control and Prevention in 2014, over 14.8 million of the U.S. population had GI diseases. Europe is the second leading market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for Clonorchiasis. Asia Pacific clonorchiasis market is majorly driven by India, China, and South Korea owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market. China has the largest population of infected people with Clonorchis sinensis. In 2013, over 13 million people were infected in China. The Middle East and Africa contribute the least in the growth of the global clonorchiasis market. However, the Middle East is dominating the market of this region. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market. Global Clonorchiasis -Major Points from TOC Chapter 1. Report Prologue Chapter 2. Market Introduction Chapter 3. Research Methodology Chapter 4. Market Dynamics Chapter 5. Market Factor Analysis Chapter 6. Global Clonorchiasis Market, By Type Chapter 7. Global Clonorchiasis Market, By Treatment Chapter 8 Global Clonorchiasis Market, By End User Chapter 9. Global Clonorchiasis Market, By Region Chapter 10 Company Landscape Chapter 11 Company Profiles Chapter 12 MRFR Conclusion Chapter 13 Appendix Avail Excusive Discount @ https://www.marketresearchfuture.com/check-discount/4686 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028
Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com